(1R,4R)-2-Oxa-5-azabicyclo[2.2.1]heptane Hydrochloride - CAS 601515-79-1
Catalog: |
BB056706 |
Product Name: |
(1R,4R)-2-Oxa-5-azabicyclo[2.2.1]heptane Hydrochloride |
CAS: |
601515-79-1 |
Synonyms: |
(1R,4R)-2-Oxa-5-azabicyclo[2.2.1]heptane Hydrochloride (1:1) |
IUPAC Name: | (1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptanehydrochloride |
Description: | (1R,4R)-2-Oxa-5-azabicyclo[2.2.1]heptane Hydrochloride, can be used as an intermediate for the synthesis of biologically active compounds, including inhibitors. |
Molecular Weight: | 135.59 |
Molecular Formula: | C5H10ClNO |
Canonical SMILES: | C1C2CNC1CO2.Cl |
InChI: | InChI=1S/C5H9NO.ClH/c1-4-3-7-5(1)2-6-4/h4-6H,1-3H21H/t4-,5-/m1./s1 |
InChI Key: | ZFOKPFPITUUCJX-TYSVMGFPSA-N |
References: | Portoghese, P. S., et al. J. Med. Chem., 14, 288 (1971). |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-113999232-A | MAT2A inhibitors | 20200728 |
WO-2022008911-A1 | Benzodiazepine derivatives useful in treating a respiratory syncytial virus infection | 20200707 |
WO-2022003575-A1 | Her2 mutation inhibitors | 20200630 |
WO-2021244608-A1 | Pyrido[2,3-b] [1,4] oxazines or tetrahydropyrido[2,3-b][1,4] oxazepines as iap antagonists | 20200604 |
WO-2021239133-A1 | Pyrimidine compound as axl inhibitor | 20200529 |
WO-2021210586-A1 | Condensed heterocyclic compound | 20200414 |
WO-2021185305-A1 | Indazole derivative and medical use thereof | 20200318 |
WO-2021116178-A1 | Pyrazolotriazines | 20191211 |
US-2021115053-A1 | Bicyclic heterocycles as fgfr inhibitors | 20191016 |
WO-2021076728-A1 | Bicyclic heterocycles as fgfr inhibitors | 20191016 |
Complexity: | 84.1 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 2 |
Defined Atom Stereocenter Count: | 2 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 135.0450916 |
Formal Charge: | 0 |
Heavy Atom Count: | 8 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 135.0450916 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 21.3Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
-
Catalog: BB054889
(+)-(2S,5R)-1-Allyl-2,5-dimethylpiperazine, (+)-Camphoric Acid Salt
Detail
-
Catalog: BB069468
(+)-(S,S,S)-Ciramadol
Detail
-
Catalog: BB069213
(-)-(18-Crown-6)-2,3,11,12-tetracarboxamide
Detail
-
Catalog: BB074330
(+)-Anymol
Detail
-
Catalog: BB055796
(-)-(1S,2R)-1,2-Dihydro-1,2-naphthalenediol
Detail
-
Catalog: BB054590
(-)-2-Pinen-4-one
Detail
-
Catalog: BB072386
(+)-(S)-(R)-BPPFA
Detail
-
Catalog: BB056914
(-)-(2S,3S)-Viridifloric Acid Acetonide
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
-
[1393527-23-5]
Phosphoric acid 6,6'-di(9-anthryl)-1,1'-spirobiindan-7,7'-diyl ester
-
[72914-19-3]
4,4'-Di-tert-butyl-2,2'-dipyridyl
-
[32449-92-6]
D-(+)-Glucurono-3,6-lactone
-
[137076-54-1]
DOTA-tris(tert-butyl ester)
-
[616-76-2]
5-Formylsalicylic acid
-
[34374-88-4]
2,4,6-Trihydroxybenzene-1,3,5-tricarbaldehyde
INDUSTRY LEADERS TRUST OUR PRODUCTS